Sorry, but we have some shocking news to report: That hair loss stock you bought may not be quite as promising as you were led to believe. A release from Vancouver-based Replicel, which takes “dermal sheath cup cells…from a subject’s own healthy hair follicles,” replicates them “into the millions over a three month period,” and … Continue reading Hair today, gone tomorrow: Hair loss company retracts public statements
Duplication has, as we noted on Twitter the other day, been tripping up more and more scientists. And now self-plagiarism has snared a prominent Columbia University chemist in a paper that left many people scratching their heads to begin with. As reported by the Chembark blog and Nature, the Journal of the American Chemical Society … Continue reading JACS temporarily pulls “space dinosaurs” paper for alleged duplication
The journal Basic and Applied Social Psychology has retracted two articles by Diederik Stapel, the Dutch researcher who has admitted falsifying his data. Stapel was suspended from his post at Tilburg University in September. Here are the notices, which appear together:
Cytokine had an interesting retraction notice this year that points up the pitfalls — perhaps necessary, perhaps not — that journals can step in when they give authors the benefit of the doubt. Here’s the story: A doctoral student named Varun Kesherwani was working in the lab of Ajit Sodhi, a U.S.-trained and well-published cell biologist … Continue reading Authors’ public dispute over retraction notice in Cytokine ends in a draw, bruises journal
Retraction Watch readers who’ve read Rebecca Skloot’s bestseller The Immortal Life of Henrietta Lacks may remember that decades ago, scientists began realizing that Lacks’s cells, now known as the HeLa cell line and used in labs around the world, were so good at proliferating that they had taken over many other cell lines researchers use … Continue reading The HeLa problem: What a retraction says about whether cancer researchers can trust their cell lines
The Journal of Neurochemistry has retracted a 2008 paper, “Toll-like receptor 3 contributes to spinal glial activation and tactile allodynia after nerve injury,” it had initially corrected — and how. The correction, which appeared online in August 2010, was extensive:
Normally we’d make hay with the following notice in Acta Biochimica et Biophysica Sinica — separating the wheat from the chaff, Love and Death, and all that — but, well, it speaks for itself (sort of). A group of researchers in China have retracted their 2011 paper on the biochemistry of chloroplast in wheat:
A partial retraction has joined the ten retractions and five corrections of Anil Potti’s papers, this one of a 2008 paper in Molecular Cancer Therapeutics. The move comes 14 months after the retraction of the Nature Medicine paper upon which much of the Molecular Cancer Therapeutics paper was based. Here’s the notice:
After five years of operation, the Nature Publishing Group is will no longer accept submissions to its preprint server Nature Precedings, having found the experiment “unsustainable as it was originally conceived.” Here’s the announcement sent to all Nature Precedings registrants this morning:
The retraction count for Dipak Das, the resveratrol researcher whom the University of Connecticut found to have committed 145 counts of fabrication and falsification of data, has risen to eight with withdrawals by Free Radical Biology & Medicine and Free Radical Research. The two Free Radical Biology & Medicine retractions, for “Expression of the longevity … Continue reading Three more retractions for resveratrol researcher Dipak Das, in free radical journals